← Back to Clinical Trials
Recruiting NCT07099027

NCT07099027 The Lung Health Check Pilot

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07099027
Status Recruiting
Phase
Sponsor Royal College of Surgeons, Ireland
Condition Non-Small Cell Lung Cancer
Study Type INTERVENTIONAL
Enrollment 2,183 participants
Start Date 2025-05-19
Primary Completion 2026-02-15

Trial Parameters

Condition Non-Small Cell Lung Cancer
Sponsor Royal College of Surgeons, Ireland
Study Type INTERVENTIONAL
Phase N/A
Enrollment 2,183
Sex ALL
Min Age 55 Years
Max Age 74 Years
Start Date 2025-05-19
Completion 2026-02-15
Interventions
Low dose CT

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study aims to test if it is feasible to introduce lung cancer screening in Ireland. People within a certain age group, who smoke or who smoked in the past, are at a greater risk of developing lung cancer. They can also develop chronic lung conditions that can affect their long-term health. In Ireland, about 2,690 people are diagnosed with Lung Cancer every year. Unfortunately, 2 out of every 3 people diagnosed with lung cancer die per year. The goal of this study is to try to screen for lung cancer in people before they have symptoms associated with the disease. We aim to do this by selecting people based on their age, whether they have smoked in the past or currently smoke as well as other relevant factors. People who take part in this study will have an assessment of how their lungs work and a low-dose CT scan. This is called a lung health check. The goal of the low-dose CT scan is to pick up lung cancer before it becomes symptomatic, and at an earlier stage. This scan uses a very low dose of radiation. Unfortunately, without early detection, such as is the goal of this trial, 8 out of 10 people who go on to develop lung cancer will have advanced lung cancer when it is discovered, where outcomes tend to be poor. The earlier detection of lung cancer has a greater potential for treatment. Current international recommendations suggest carrying out these scans in the community rather than in a hospital. Therefore, we aim to deliver these lung health checks using a mobile unit in the community. This study aims to test if we will successfully pick up lung cancer earlier by doing community-based 'lung health check's using mobile units in North Dublin and the North East, among people of a certain age and smoking history.

Eligibility Criteria

Inclusion Criteria: 1. 55 - 74 years of age 2. Current or former smokers * Current: \>100 cigarettes in lifetime and/or currently tobacco smoking * Former: \>100 cigarettes in lifetime and/or no tobacco smoking \>= 28 days 3. Referred from a GP for the LHC pilot 4. PLCOM2012 ≥ 1.51% or LLPv2 ≥2.5% (Lung Cancer Risk Scores) * Prostate Lung Cancer Colorectal Ovarian (PLCO) \& Liverpool Lung Project Version 2 (LLPv2) Exclusion Criteria: 1. Participant-reported history of chest CT in the last 12 months 2. Inability to undergo non-contrast CT (e.g. \>200 kg body weight, inability to lie flat) 3. Participant reported known diagnosis of other advanced stage cancers 4. Participant reported diagnosis of lung cancer of any stage in the last 5 years 5. Likely non-compliance with study procedures, as determined by the participant i) Unable to provide informed consent ii) Inability to attend study visits 6. Nursing home residents -

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology